United States · FDA National Drug Code directory

JYNNEOS

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 50632-002_b8f81332-4a93-4b01-89b9-3952565ab2e9
Product NDC: 50632-002
Form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Composition / generic term: Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen
Labeler: Bavarian Nordic A/S
Marketing category: BLA
Marketing start / end (source format): 20250414
Source listing expiry: 20261231

Source-listed ingredients

VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN — 50000000 1/.5mL

These values do not establish equivalence or a dose recommendation.

Packages

20 VIAL in 1 CARTON (50632-002-02) / .5 mL in 1 VIAL (50632-002-01) · 50632-002-02

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →